SCHEMBL4906196

SCHEMBL4906196

CCOc1ccc2nc(SN(CC)S(=O)(=O)c3cc(C)c(C)c(C(=O)OC)c3)sc2c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.47
MAPT P10636 7/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HTT P42858 1/20 0.47
ALOX5 P09917 2/20 0.46
LMNA P02545 5/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
GAA P10253 1/20 0.44
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902985 0.92 PPARA (0.49) PPARAMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL4908602 0.91 PPARA (0.48) PPARAMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL4904126 0.87 ALDH1A1 (0.45) MAPTSMN1; SMN2ALDH1A1HTTALOX5
SCHEMBL4903636 0.84 PPARA (0.50) PPARAMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL4902801 0.83 CYP1A2 (0.45) PPARASMN1; SMN2ALDH1A1ALOX5LMNA
SCHEMBL4906185 0.81 MAPT (0.68) PPARAMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL4905953 0.77 ALDH1A1 (0.46) MAPTSMN1; SMN2HPGDALDH1A1HTT
SCHEMBL4900796 0.77 MEN1 (0.43) MAPTSMN1; SMN2HPGDALDH1A1HTT
SCHEMBL4908596 0.74 MAPT (0.70) PPARAMAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL4904210 0.74 KDM4E (0.40) SMN1; SMN2HPGDALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PPARA 1/4885MAPT 1858/4885SMN1; SMN2 3271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PPARA 1/4885MAPT 1786/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.